Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

Jorgensen, H G and Allan, E K and Mountford, J C and Richmond, L and Elliott, M A and Holyoake, T L (2004) Enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro. Blood, 104 (11). 551A-551A. ISSN 0006-4971

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

Meeting abstract 1997 looks at enhanced primary CML stem cell elimination by bryostatin priming with imatinib mesylate in vitro

Item type: Article
ID code: 34850
Keywords: enhanced, primary cml stem cell elimination, bryostatin priming, imatinib mesylate , in vitro, Pharmacy and materia medica, Biochemistry, Cell Biology, Immunology, Hematology
Subjects: Medicine > Pharmacy and materia medica
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
    Depositing user: Pure Administrator
    Date Deposited: 21 Nov 2011 15:00
    Last modified: 05 Sep 2014 12:25
    URI: http://strathprints.strath.ac.uk/id/eprint/34850

    Actions (login required)

    View Item